Senate to ignore OTC regulatory arbitrage

January 11 2010

Despite recent fears that the US and Europe are diverging on OTC derivatives regulation, the US Senate is unlikely to consider the prospect of regulatory arbitrage when legislating

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Banking Structured finance and Securitisation European Union Features Capital Markets United States